May 5, 2026
Scientists have identified a previously unknown immune mechanism where the chloride channel PACC1 plays a crucial role in helping immune cells kill bacteria, offering a potential new therapeutic target for sepsis.
Mayo Clinic researchers have developed a new method to identify which proteins are most likely to trigger an immune response, a discovery that could help improve transplant care and regenerative medicine outcomes.
Scripps Research scientists have developed a first-in-class drug compound that reduces harmful inflammation while leaving the body's ability to fight infections intact, addressing a long-sought goal in treating autoimmune diseases.